Home/Filings/4/0001062993-23-022644
4//SEC Filing

Lask Alisa 4

Accession 0001062993-23-022644

CIK 0001196298other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:48 PM ET

Size

11.0 KB

Accession

0001062993-23-022644

Insider Transaction Report

Form 4
Period: 2023-12-13
Lask Alisa
Director
Transactions
  • Award

    Common Stock

    2023-12-13+9,29148,629 total
Holdings
  • Stock Option (right to buy)

    Exercise: $5.22Exp: 2029-02-08Common Stock (9,617 underlying)
    9,617
  • Stock Option (right to buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
    5,568
  • Stock Option (right to buy)

    Exercise: $8.06Exp: 2031-01-06Common Stock (6,850 underlying)
    6,850
  • Stock Option (right to buy)

    Exercise: $6.82Exp: 2031-12-14Common Stock (7,062 underlying)
    7,062
  • Stock Option (right to buy)

    Exercise: $1.07Exp: 2033-01-05Common Stock (7,080 underlying)
    7,080
Footnotes (4)
  • [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date.
  • [F2]Fully exercisable.
  • [F3]This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.
  • [F4]This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001767593

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:48 PM ET
Size
11.0 KB